RAONF Stock - Race Oncology Limited
Unlock GoAI Insights for RAONF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.04M | $4.00M | $3.13M | $707,807 | $387,385 |
| Gross Profit | $5.41M | $2.22M | $2.85M | $426,611 | $106,189 |
| Gross Margin | 89.5% | 55.5% | 91.0% | 60.3% | 27.4% |
| Operating Income | $-3,771,834 | $-12,547,982 | $-9,532,113 | $-10,443,919 | $-5,769,788 |
| Net Income | $-4,787,258 | $-13,819,000 | $-9,923,000 | $-11,202,000 | $-6,340,000 |
| Net Margin | -79.2% | -345.2% | -316.6% | -1582.6% | -1636.6% |
| EPS | $-0.03 | $-0.08 | $-0.06 | $-0.07 | $-0.05 |
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.
Visit WebsiteEarnings History & Surprises
RAONFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q3 2025 | Jul 21, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | $0.00 | — | — |
Q4 2024 | Oct 20, 2024 | — | $0.00 | — | — |
Q3 2024 | Aug 27, 2024 | — | $-0.03 | — | — |
Q2 2024 | Apr 17, 2024 | — | $-0.02 | — | — |
Q1 2024 | Feb 27, 2024 | — | $-0.02 | — | — |
Q1 2024 | Jan 29, 2024 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.02 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.03 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about RAONF
What is RAONF's current stock price?
What is the analyst price target for RAONF?
What sector is Race Oncology Limited in?
What is RAONF's market cap?
Does RAONF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RAONF for comparison